Search research articles
Contact Us
Filters
Showing results (141-150 of 169) with videos related to
Page
of 17
Sort By:
Mycologia
|
March 11, 2009
Taxonomy and phylogeny of the Fusarium dimerum species group
Hans-Josef Schroers, Kerry O'Donnell, Sandra C Lamprecht, et al.
Journal of Clinical Gastroenterology
|
November 29, 2023
Fecal Microbiota, Live-jslm for the Prevention of Recurrent Clostridioides difficile Infection : Subgroup Analysis of PUNCH CD2 and PUNCH CD3
Paul Feuerstadt, Carl V Crawford, Xing Tan, et al.
The Lancet. Microbe
|
June 29, 2025
Clostridioides difficile should be considered a bacterial priority pathogen
Wiep Klaas Smits, Kevin W Garey, Thomas V Riley, et al.
Anaerobe
|
June 11, 2018
Molecular epidemiology of Clostridioides (Clostridium) difficile strains recovered from clinical trials in the US, Canada and Europe from 2006-2009 to 2012-2015
Adam Cheknis, Stuart Johnson, Laurent Chesnel, et al.
Anaerobe
|
September 10, 2009
Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007
Adam K Cheknis, Susan P Sambol, David M Davidson, et al.
Emerging Infectious Diseases
|
July 5, 2008
Toxinotype V Clostridium difficile in humans and food animals
Michael A Jhung, Angela D Thompson, George E Killgore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 1, 2020
Efficacy of Bezlotoxumab in Trial Participants Infected With Clostridioides difficile Strain BI Associated With Poor Outcomes
Stuart Johnson, Diane M Citron, Dale N Gerding, et al.
Food & Function
|
January 9, 2020
The effect of regular consumption of lupin-containing foods on glycaemic control and blood pressure in people with type 2 diabetes mellitus
Natalie C Ward, Trevor A Mori, Lawrence J Beilin, et al.
BMC Infectious Diseases
|
March 13, 2022
Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial
Robert Orenstein, Erik R Dubberke, Sahil Khanna, et al.
Nature
|
March 3, 2009
Toxin B is essential for virulence of Clostridium difficile
Dena Lyras, Jennifer R O'Connor, Pauline M Howarth, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 169) with videos related to
Sort By:
Page
of 17
Mycologia
|
March 11, 2009
Taxonomy and phylogeny of the Fusarium dimerum species group
Hans-Josef Schroers, Kerry O'Donnell, Sandra C Lamprecht, et al.
Journal of Clinical Gastroenterology
|
November 29, 2023
Fecal Microbiota, Live-jslm for the Prevention of Recurrent Clostridioides difficile Infection : Subgroup Analysis of PUNCH CD2 and PUNCH CD3
Paul Feuerstadt, Carl V Crawford, Xing Tan, et al.
The Lancet. Microbe
|
June 29, 2025
Clostridioides difficile should be considered a bacterial priority pathogen
Wiep Klaas Smits, Kevin W Garey, Thomas V Riley, et al.
Anaerobe
|
June 11, 2018
Molecular epidemiology of Clostridioides (Clostridium) difficile strains recovered from clinical trials in the US, Canada and Europe from 2006-2009 to 2012-2015
Adam Cheknis, Stuart Johnson, Laurent Chesnel, et al.
Anaerobe
|
September 10, 2009
Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007
Adam K Cheknis, Susan P Sambol, David M Davidson, et al.
Emerging Infectious Diseases
|
July 5, 2008
Toxinotype V Clostridium difficile in humans and food animals
Michael A Jhung, Angela D Thompson, George E Killgore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 1, 2020
Efficacy of Bezlotoxumab in Trial Participants Infected With Clostridioides difficile Strain BI Associated With Poor Outcomes
Stuart Johnson, Diane M Citron, Dale N Gerding, et al.
Food & Function
|
January 9, 2020
The effect of regular consumption of lupin-containing foods on glycaemic control and blood pressure in people with type 2 diabetes mellitus
Natalie C Ward, Trevor A Mori, Lawrence J Beilin, et al.
BMC Infectious Diseases
|
March 13, 2022
Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial
Robert Orenstein, Erik R Dubberke, Sahil Khanna, et al.
Nature
|
March 3, 2009
Toxin B is essential for virulence of Clostridium difficile
Dena Lyras, Jennifer R O'Connor, Pauline M Howarth, et al.
Page
of 17